Home›Search›Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

Elsevier Editora Ltda · Brazil · Est. 1977

ISSN2531-1387

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.37

H-Indexi

SNIPi

0.754

Total Worksi

10,988

Total Citationsi

7,479

2yr Mean Citednessi

0.08

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Hematology; Immunology and Allergy.

General Information

Country / RegionBrazil

Primary LanguageEnglish

1st Year Published1977

Annual Volume~ 2,278 articles / year

StatusActive (last: 2026)

Total Publications10,988

Publisher OrgElsevier BV

OA Since2017

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Elsevier Editora Ltda

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2531-1387

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

103

1.1k

2019

1.2k

1.8k

2020

1.2k

2021

1.4k

735

2022

1.9k

527

2023

2.5k

449

2024

2.4k

102

2025

153

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ3

Immunology and AllergyQ4

Subject Classification

Scopus Categories

HematologyImmunology and Allergy

Research Topics (OpenAlex)

Hemoglobinopathies and Related DisordersAcute Myeloid Leukemia ResearchBlood donation and transfusion practicesChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchIron Metabolism and DisordersHealthcare during COVID-19 PandemicChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and TreatmentBlood groups and transfusion

Frequently asked questions about Hematology, Transfusion and Cell Therapy

Is Hematology, Transfusion and Cell Therapy a predatory journal?

PubScope has no integrity flags on record for Hematology, Transfusion and Cell Therapy: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Hematology, Transfusion and Cell Therapy?

Hematology, Transfusion and Cell Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.37.

Is Hematology, Transfusion and Cell Therapy indexed in Scopus and Web of Science?

Hematology, Transfusion and Cell Therapy is indexed in Scopus, DOAJ.

What is the aims and scope of Hematology, Transfusion and Cell Therapy?